Frontiers in Cell and Developmental Biology (Nov 2021)

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Accelerate Functional Recovery After Spinal Cord Injury by Promoting the Phagocytosis of Macrophages to Clean Myelin Debris

  • Xiaolong Sheng,
  • Xiaolong Sheng,
  • Xiaolong Sheng,
  • Xiaolong Sheng,
  • Jinyun Zhao,
  • Jinyun Zhao,
  • Jinyun Zhao,
  • Jinyun Zhao,
  • Miao Li,
  • Miao Li,
  • Miao Li,
  • Miao Li,
  • Miao Li,
  • Yan Xu,
  • Yan Xu,
  • Yan Xu,
  • Yan Xu,
  • Yi Zhou,
  • Yi Zhou,
  • Yi Zhou,
  • Yi Zhou,
  • Yi Zhou,
  • Jiaqi Xu,
  • Jiaqi Xu,
  • Jiaqi Xu,
  • Jiaqi Xu,
  • Rundong He,
  • Rundong He,
  • Rundong He,
  • Rundong He,
  • Hongbin Lu,
  • Hongbin Lu,
  • Hongbin Lu,
  • Hongbin Lu,
  • Tianding Wu,
  • Tianding Wu,
  • Tianding Wu,
  • Tianding Wu,
  • Chunyue Duan,
  • Chunyue Duan,
  • Chunyue Duan,
  • Chunyue Duan,
  • Yong Cao,
  • Yong Cao,
  • Yong Cao,
  • Yong Cao,
  • Jianzhong Hu,
  • Jianzhong Hu,
  • Jianzhong Hu,
  • Jianzhong Hu

DOI
https://doi.org/10.3389/fcell.2021.772205
Journal volume & issue
Vol. 9

Abstract

Read online

Macrophage phagocytosis contributes predominantly to processing central nervous system (CNS) debris and further facilitates neurological function restoration after CNS injury. The aims of this study were to evaluate the effect of bone marrow mesenchymal stem cells (BMSC)-derived exosomes (BMSC-Exos) on the phagocytic capability of macrophages to clear myelin debris and to investigate the underlying molecular mechanism during the spinal cord injury (SCI) process. This work reveals that monocyte-derived macrophages (MDMs) infiltrating into the SCI site could efficiently engulf myelin debris and process phagocytic material. However, the phagocytic ability of macrophages to clear tissue debris is compromised after SCI. The administration of BMSC-Exos as an approach for SCI treatment could rescue macrophage normal function by improving the phagocytic capability of myelin debris internalization, which is beneficial for SCI repair, as evidenced by better axon regrowth and increased hindlimb locomotor functional recovery in a rodent model. Examination of macrophage treatment with BMSC-Exos revealed that BMSC-Exos could promote the capacity of macrophages to phagocytose myelin debris in vitro and could create a regenerative microenvironment for axon regrowth. In addition, we confirmed that BMSC-Exo treatment resulted in improved phagocytosis of engulfed myelin debris by promoting the expression of macrophage receptor with collagenous structure (MARCO) in macrophages. The inhibition of MARCO with PolyG (a MARCO antagonist) impaired the effect of BMSC-Exos on the phagocytic capacity of macrophages and resulted in compromised myelin clearance at the lesion site, leading to further tissue damage and impaired functional healing after SCI. In conclusion, these data indicated that targeting the phagocytic ability of macrophages may have therapeutic potential for the improvement in functional healing after SCI. The administration of BMSC-Exos as a cell-free immune therapy strategy has wide application prospects for SCI treatment.

Keywords